• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

    12/12/22 5:01:05 PM ET
    $GOCO
    Specialty Insurers
    Finance
    Get the next $GOCO alert in real time by email
    SC 13D/A 1 d224226dsc13da.htm SC 13D/A SC 13D/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

    SCHEDULE 13D

    Under the Securities Exchange Act of 1934

    (Amendment No. 2)*

     

     

    GoHealth, Inc.

    (Name of Issuer)

    Class A Common Stock, par value $0.0001 per share

    (Title of Class of Securities)

    38046W105

    (CUSIP Number)

    Susanne V. Clark

    c/o Centerbridge Partners, L.P.

    375 Park Avenue, 11th Floor

    New York, NY 10152

    (212) 672-5000

    (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

    December 7, 2022

    (Date of Event Which Requires Filing of This Statement)

     

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box.  ☐

     

     

    Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent.

     

     

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

    The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    CUSIP No. 38046W105    13D    Page 1 of 16 pages

     

      1    

      Names of Reporting Persons

     

      CCP III Cayman GP Ltd.

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      OO

      5  

      Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      Cayman Islands

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7     

      Sole Voting Power

     

      0

         8   

      Shared Voting Power

     

      9,459,897

         9   

      Sole Dispositive Power

     

      0

       10   

      Shared Dispositive Power

     

      9,459,897

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      9,459,897

    12  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13  

      Percent of Class Represented by Amount in Row (11)

     

      66.3%

    14  

      Type of Reporting Person

     

      CO


    CUSIP No. 38046W105    13D    Page 2 of 16 pages

     

      1    

      Names of Reporting Persons

     

      CB Blizzard Holdings C, L.P.

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      OO

      5  

      Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7     

      Sole Voting Power

     

      0

         8   

      Shared Voting Power

     

      1,361,522

         9   

      Sole Dispositive Power

     

      0

       10   

      Shared Dispositive Power

     

      1,361,522

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      1,361,522

    12  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13  

      Percent of Class Represented by Amount in Row (11)

     

      15.3%

    14  

      Type of Reporting Person

     

      PN


    CUSIP No. 38046W105    13D    Page 3 of 16 pages

     

      1    

      Names of Reporting Persons

     

      Centerbridge Associates III, L.P.

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      OO

      5  

      Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7     

      Sole Voting Power

     

      0

         8   

      Shared Voting Power

     

      2,712,197

         9   

      Sole Dispositive Power

     

      0

       10   

      Shared Dispositive Power

     

      2,712,197

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      2,712,197

    12  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13  

      Percent of Class Represented by Amount in Row (11)

     

      30.5%

    14  

      Type of Reporting Person

     

      PN


    CUSIP No. 38046W105    13D    Page 4 of 16 pages

     

      1    

      Names of Reporting Persons

     

      CCP III AIV VII Holdings, L.P.

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      OO

      5  

      Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7     

      Sole Voting Power

     

      0

         8   

      Shared Voting Power

     

      2,712,197

         9   

      Sole Dispositive Power

     

      0

       10   

      Shared Dispositive Power

     

      2,712,197

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      2,712,197

    12  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13  

      Percent of Class Represented by Amount in Row (11)

     

      30.5%

    14  

      Type of Reporting Person

     

      PN


    CUSIP No. 38046W105    13D    Page 5 of 16 pages

     

      1    

      Names of Reporting Persons

     

      CB Blizzard Co-Invest Holdings, L.P.

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      OO

      5  

      Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7     

      Sole Voting Power

     

      0

         8   

      Shared Voting Power

     

      2,712,197

         9   

      Sole Dispositive Power

     

      0

       10   

      Shared Dispositive Power

     

      2,712,197

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      2,712,197

    12  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13  

      Percent of Class Represented by Amount in Row (11)

     

      30.5%

    14  

      Type of Reporting Person

     

      PN


    CUSIP No. 38046W105    13D    Page 6 of 16 pages

     

      1    

      Names of Reporting Persons

     

      CB Blizzard Lower Holdings GP A, LLC

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      OO

      5  

      Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7     

      Sole Voting Power

     

      0

         8   

      Shared Voting Power

     

      2,712,197

         9   

      Sole Dispositive Power

     

      0

       10   

      Shared Dispositive Power

     

      2,712,197

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      2,712,197

    12  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13  

      Percent of Class Represented by Amount in Row (11)

     

      30.5%

    14  

      Type of Reporting Person

     

      OO (Limited Liability Company)


    CUSIP No. 38046W105    13D    Page 7 of 16 pages

     

      1    

      Names of Reporting Persons

     

      CB Blizzard Lower Holdings A, L.P.

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      OO

      5  

      Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7     

      Sole Voting Power

     

      0

         8   

      Shared Voting Power

     

      2,712,197

         9   

      Sole Dispositive Power

     

      0

       10   

      Shared Dispositive Power

     

      2,712,197

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      2,712,197

    12  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13  

      Percent of Class Represented by Amount in Row (11)

     

      30.5%

    14  

      Type of Reporting Person

     

      PN


    CUSIP No. 38046W105    13D    Page 8 of 16 pages

     

     

      1    

      Names of Reporting Persons

     

      Blizzard Aggregator, LLC

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      OO

      5  

      Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7     

      Sole Voting Power

     

      0

         8   

      Shared Voting Power

     

      5,386,178

         9   

      Sole Dispositive Power

     

      0

       10   

      Shared Dispositive Power

     

      5,386,178

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      5,386,178

    12  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13  

      Percent of Class Represented by Amount in Row (11)

     

      37.7%

    14  

      Type of Reporting Person

     

      OO (Limited Liability Company)


    CUSIP No. 38046W105    13D    Page 9 of 16 pages

     

      1    

      Names of Reporting Persons

     

      CB Blizzard Lower Holdings GP B, LLC

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      OO

      5  

      Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7    

      Sole Voting Power

     

      0

         8  

      Shared Voting Power

     

      5,386,178

         9  

      Sole Dispositive Power

     

      0

       10  

      Shared Dispositive Power

     

      5,386,178

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      5,386,178

    12  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13  

      Percent of Class Represented by Amount in Row (11)

     

      37.7%

    14  

      Type of Reporting Person

     

      OO (Limited Liability Company)


    CUSIP No. 38046W105    13D    Page 10 of 16 pages

     

      1    

      Names of Reporting Persons

     

      CB Blizzard Lower Holdings B, L.P.

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      OO

      5  

      Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7    

      Sole Voting Power

     

      0

         8  

      Shared Voting Power

     

      5,386,178

         9  

      Sole Dispositive Power

     

      0

       10  

      Shared Dispositive Power

     

      5,386,178

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      5,386,178

    12  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13  

      Percent of Class Represented by Amount in Row (11)

     

      37.7%

    14  

      Type of Reporting Person

     

      PN


    CUSIP No. 38046W105    13D    Page 11 of 16 pages

     

      1    

      Names of Reporting Persons

     

      Jeffrey H. Aronson

      2  

      Check the Appropriate Box if a Member of a Group (See Instructions)

      (a)  ☐        (b)  ☒

     

      3  

      SEC Use Only

     

      4  

      Source of Funds (See Instructions)

     

      OO

      5  

      Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

     

      ☐

      6  

      Citizenship or Place of Organization

     

      United States

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH

     

         7    

      Sole Voting Power

     

      0

         8  

      Shared Voting Power

     

      9,459,897

         9  

      Sole Dispositive Power

     

      0

       10  

      Shared Dispositive Power

     

      9,459,897

    11    

      Aggregate Amount Beneficially Owned by Each Reporting Person

     

      9,459,897

    12  

      Check if the Aggregate Amount in Row (11) Excludes Certain Shares

     

      ☐

    13  

      Percent of Class Represented by Amount in Row (11)

     

      66.3%

    14  

      Type of Reporting Person

     

      IN


    CUSIP No. 38046W105    13D    Page 12 of 16 pages

     

    Explanatory Note

    This Amendment No. 2 to Schedule 13D (“Amendment No. 2”) amends and supplements the Schedule 13D originally filed with the United States Securities and Exchange Commission on November 25, 2022 (as amended to date, the “Schedule 13D”), relating to the shares of Class A Common Stock, par value $0.0001 per share (the “Class A Common Stock”), of GoHealth, Inc., a Delaware corporation (the “Issuer”). Capitalized terms used herein without definition shall have the meanings set forth in the Schedule 13D.

    Item 3. Source and Amount of Funds or Other Consideration.

    Item 3 of the Schedule 13D is hereby amended and supplemented by inserting the following information at the end of Item 3:

    From December 1, 2022 to December 9, 2022, CB Blizzard C purchased 246,391 shares of Class A Common Stock for aggregate consideration of approximately $3.2 million in a series of open-market transactions.

    The Reporting Persons obtained the funds used to acquire their interests in the Issuer’s securities through capital contributions from their partners and members.


    CUSIP No. 38046W105    13D    Page 13 of 16 pages

     

    Item 5. Interest in Securities of the Issuer.

    Item 5 of the Schedule 13D is hereby amended and restated in its entirety as follows:

    (a) – (b)

    The following sets forth, as of the date of this Schedule 13D, the aggregate number of shares of Class A Common Stock and percentage of Class A Common Stock beneficially owned by each of the Reporting Persons, as well as the number of shares of Class A Common Stock as to which each Reporting Person has the sole power to vote or to direct the vote, shared power to vote or to direct the vote, sole power to dispose or to direct the disposition of, or shared power to dispose or to direct the disposition of, as of the date hereof, based on 8,890,469 shares of Class A Common Stock outstanding as of November 18, 2022 following the Stock Split, as provided by the Issuer, plus, as applicable, 5,386,178 shares of Class A Common Stock underlying the LLC Interests held of record by CB Blizzard B:

     

    Reporting Person

       Amount
    beneficially
    owned
         Percent
    of class
        Sole power
    to vote or
    to direct
    the vote
       Shared
    power to
    vote or to
    direct the
    vote
         Sole power
    to dispose
    or to direct
    the
    disposition
       Shared
    power to
    dispose or to
    direct the
    disposition
     

    CCP III Cayman GP Ltd.

         9,459,897        66.3 %    0      9,459,897      0      9,459,897  

    CB Blizzard Holdings C, L.P.

         1,361,522        15.3 %    0      1,361,522      0      1,361,522  

    Centerbridge Associates III, L.P.

         2,712,197        30.5 %    0      2,712,197      0      2,712,197  

    CCP III AIV VII Holdings, L.P.

         2,712,197        30.5 %    0      2,712,197      0      2,712,197  

    CB Blizzard Co-Invest Holdings, L.P.

         2,712,197        30.5 %    0      2,712,197      0      2,712,197  

    CB Blizzard Lower Holdings GP A, LLC

         2,712,197        30.5 %    0      2,712,197      0      2,712,197  

    CB Blizzard Lower Holdings A, L.P.

         2,712,197        30.5 %    0      2,712,197      0      2,712,197  

    Blizzard Aggregator, LLC

         5,386,178        37.7 %    0      5,386,178      0      5,386,178  

    CB Blizzard Lower Holdings GP B, LLC

         5,386,178        37.7 %    0      5,386,178      0      5,386,178  

    CB Blizzard Lower Holdings B, L.P.

         5,386,178        37.7 %    0      5,386,178      0      5,386,178  

    Jeffrey H. Aronson

         9,459,897        66.3 %    0      9,459,897      0      9,459,897  

    CB Blizzard A is the record holder of 2,712,197 shares of Class A Common Stock. CB Blizzard C is the record holder of 1,361,522 shares of Class A Common Stock. CB Blizzard B is the record holder of 5,386,178 LLC Interests. Each of these figures are presented on a post-split basis.


    CUSIP No. 38046W105    13D    Page 14 of 16 pages

     

    CCP GP is the general partner of CB Blizzard C and may be deemed to share beneficial ownership of the securities held of record by CB Blizzard C. CCP GP is also the general partner of Centerbridge Associates III, L.P., which is the general partner of each of CCP III AIV VII Holdings, L.P. and CB Blizzard Co-Invest Holdings, L.P., which are the owners of CB Blizzard Lower Holdings GP A, LLC, which is the general partner of CB Blizzard A. As a result, each of the foregoing entities may be deemed to share beneficial ownership of the securities held of record by CB Blizzard A. CCP GP is also the sole manager of Blizzard Aggregator, LLC, which is the owner of CB Blizzard Lower Holdings GP B, LLC, which is the general partner of CB Blizzard B. As a result, each of the foregoing entities may be deemed to share beneficial ownership of the LLC Interests held of record by CB Blizzard B.

    Jeffrey H. Aronson is the sole director of CCP GP and, as a result, may be deemed to share beneficial ownership of the securities held of record by each of CB Blizzard A, CB Blizzard C and CB Blizzard B. However, none of the foregoing should be construed in and of itself as an admission by Mr. Aronson or by any Reporting Person as to beneficial ownership of securities owned by another Reporting Person. In addition, Mr. Aronson expressly disclaims beneficial ownership of the securities held of record by each of CB Blizzard A, CB Blizzard C and CB Blizzard B.

    In addition, as discussed in Item 2 of the Schedule 13D, by virtue of the agreements made pursuant to the Stockholders Agreement, the Stockholders may be deemed to be acting as a group for purposes of Rule 13d-3 under the Exchange Act. Shares beneficially owned by NVX are not the subject of this Schedule 13D and accordingly, NVX is not included as a reporting person herein.

    (c) Except as described in Item 3 of the Schedule 13D, during the past 60 days, the Reporting Persons have not effected any transactions with respect to the Class A Common Stock.

    (d) None.

    (e) Not applicable.


    CUSIP No. 38046W105    13D    Page 15 of 16 pages

     

    SIGNATURES

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    Date: December 12, 2022

     

    CCP III Cayman GP Ltd.
    By:  

    /s/ Susanne V. Clark

    Name:   Susanne V. Clark
    Title:   Authorized Signatory
    CB Blizzard Holdings C, L.P.
    By: CCP III Cayman GP Ltd., its general partner
    By:  

    /s/ Susanne V. Clark

    Name:   Susanne V. Clark
    Title:   Authorized Signatory
    Centerbridge Associates III, L.P.
    By: CCP III Cayman GP Ltd., its general partner
    By:  

    /s/ Susanne V. Clark

    Name:   Susanne V. Clark
    Title:   Authorized Signatory
    CCP III AIV VII Holdings, L.P.
    By: Centerbridge Associates III, L.P., its general partner
    By: CCP III Cayman GP Ltd., its general partner
    By:  

    /s/ Susanne V. Clark

    Name:   Susanne V. Clark
    Title:   Authorized Signatory
    CB Blizzard Co-Invest Holdings, L.P.
    By: Centerbridge Associates III, L.P., its general partner
    By: CCP III Cayman GP Ltd., its general partner
    By:  

    /s/ Susanne V. Clark

    Name:   Susanne V. Clark
    Title:   Authorized Signatory


    CUSIP No. 38046W105    13D    Page 16 of 16 pages

     

    CB Blizzard Lower Holdings GP A, LLC
    By:  

    /s/ Susanne V. Clark

    Name:   Susanne V. Clark
    Title:   Authorized Signatory
    CB Blizzard Lower Holdings A, L.P.
    By: CB Blizzard Lower Holdings GP A, LLC, its general partner
    By:  

    /s/ Susanne V. Clark

    Name:   Susanne V. Clark
    Title:   Authorized Signatory
    Blizzard Aggregator, LLC
    By: CCP III Cayman GP Ltd., its sole manager
    By:  

    /s/ Susanne V. Clark

    Name:   Susanne V. Clark
    Title:   Authorized Signatory
    CB Blizzard Lower Holdings GP B, LLC
    By:  

    /s/ Susanne V. Clark

    Name:   Susanne V. Clark
    Title:   Authorized Signatory
    CB Blizzard Lower Holdings B, L.P.
    By: CB Blizzard Lower Holdings GP B, LLC, its general partner
    By:  

    /s/ Susanne V. Clark

    Name:   Susanne V. Clark
    Title:   Authorized Signatory
    Jeffrey H. Aronson

    /s/ Jeffrey H. Aronson

    Get the next $GOCO alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $GOCO

    DatePrice TargetRatingAnalyst
    4/1/2022$1.50Underperform
    Credit Suisse
    3/3/2022$10.00 → $2.00Outperform → Sector Perform
    RBC Capital
    3/2/2022Buy → Hold
    Truist
    3/2/2022$2.00Buy → Hold
    Truist Securities
    1/7/2022$6.00 → $3.00Neutral → Underperform
    Credit Suisse
    1/5/2022$7.50 → $3.50Buy → Underperform
    B of A Securities
    11/15/2021$7.00 → $6.00Neutral
    Credit Suisse
    11/11/2021$13.00 → $5.50Equal-Weight
    Morgan Stanley
    More analyst ratings

    $GOCO
    SEC Filings

    View All

    GoHealth Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - GoHealth, Inc. (0001808220) (Filer)

    8/19/25 4:20:38 PM ET
    $GOCO
    Specialty Insurers
    Finance

    Amendment: SEC Form SCHEDULE 13D/A filed by GoHealth Inc.

    SCHEDULE 13D/A - GoHealth, Inc. (0001808220) (Subject)

    8/13/25 5:28:06 PM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form SCHEDULE 13D filed by GoHealth Inc.

    SCHEDULE 13D - GoHealth, Inc. (0001808220) (Subject)

    8/13/25 5:27:38 PM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Credit Suisse resumed coverage on GoHealth with a new price target

    Credit Suisse resumed coverage of GoHealth with a rating of Underperform and set a new price target of $1.50

    4/1/22 7:10:27 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth downgraded by RBC Capital with a new price target

    RBC Capital downgraded GoHealth from Outperform to Sector Perform and set a new price target of $2.00 from $10.00 previously

    3/3/22 4:36:13 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth downgraded by Truist

    Truist downgraded GoHealth from Buy to Hold

    3/2/22 7:31:46 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    GoHealth Announces Strategic Capital and Governance Actions to Support Long-Term Value Creation and Reports Second Quarter 2025 Results

    CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced the execution of strategic capital and governance actions that are expected to significantly enhance its financial flexibility and long-term positioning along with its financial results for the three and six months ended June 30, 2025. Strategic Capital and Governance Actions Secured new senior secured superpriority term loan facility, including $80.0 million in new-money term loans and $35.0 million in roll-up loans, to support working capital and stra

    8/7/25 7:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth to Announce Strategic Capital and Governance Actions to Support Long-Term Value Creation and Second Quarter 2025 Results

    CHICAGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, will announce strategic capital and governance actions to support long-term value creation and its second quarter 2025 financial results on the morning of August 7, 2025. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss recent strategic capital and governance actions. A live audio webcast of the conference call will be available via GoHealth's Investor Relations websi

    8/6/25 4:15:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Secures Amended Credit Agreement Highlighting Broad Based Support from Stakeholders

    CHICAGO, June 30, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO), a leading health insurance marketplace, today announced it has entered into an amendment with its lenders under the Company's existing credit agreement in order to, among other things, provide covenant adjustments as well as extend the maturity of the Company's revolving credit facility through September 30, 2025. The amendment also provides consent for the Company to pursue a receivables financing (such consent also covering a securitization transaction) as the parties continue to work toward a comprehensive financing plan intended to alleviate the Company's recent going concern position, strengthen the Company's fin

    6/30/25 4:30:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    New insider Public Sector Pension Investment Board claimed ownership of 1,680,526 shares (SEC Form 3)

    3 - GoHealth, Inc. (0001808220) (Issuer)

    8/15/25 10:03:07 AM ET
    $GOCO
    Specialty Insurers
    Finance

    Chief Executive Officer Kotte Vijay was granted 218,551 shares, increasing direct ownership by 19% to 1,347,396 units (SEC Form 4)

    4 - GoHealth, Inc. (0001808220) (Issuer)

    8/8/25 4:57:12 PM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form 3 filed by new insider Carr Alan Jeffrey

    3 - GoHealth, Inc. (0001808220) (Issuer)

    8/8/25 2:44:30 PM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Kotte Vijay bought $100,275 worth of shares (7,500 units at $13.37), increasing direct ownership by 1% to 653,630 units (SEC Form 4)

    4 - GoHealth, Inc. (0001808220) (Issuer)

    11/15/23 10:10:34 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Leadership Updates

    Live Leadership Updates

    View All

    Brendan Shanahan Appointed Chief Financial Officer of GoHealth, Bringing Decades of Leadership in Healthcare and Financial Strategy

    CHICAGO, Oct. 10, 2024 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, today announced the appointment of Brendan Shanahan as Chief Financial Officer (CFO), effective October 14, following a comprehensive search process. Mr. Shanahan, a seasoned executive with over 30 years of financial leadership experience and over 20 years of expertise in the Medicare Advantage space, will oversee GoHealth's financial strategy and operations, contributing to the company's profitable growth and innovation efforts. "Brendan's extensive expertise in financial strategy, M&A, operational leadership, and deep knowledge of t

    10/10/24 9:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Appoints Vance Johnston as Chief Financial Officer

    CHICAGO, Dec. 6, 2021 /PRNewswire/ -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, announced today that Vance Johnston will join the Company as Chief Financial Officer (CFO) on December 7, 2021.  As previously announced, Travis Matthiesen, the Company's current CFO, will transition to the role of Chief Transformation Officer and will work closely with Johnston to ensure a smooth transition. "We are very pleased that Vance will be joining the GoHealth executive team as CFO," said Clint Jones, co-fou

    12/6/21 4:05:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Appoints Dr. Paul Hain, M.D. as Chief Medical Officer

    CHICAGO, Dec. 1, 2020 /PRNewswire/ -- GoHealth, Inc. (GoHealth) (NASDAQ: GOCO), a leading health insurance marketplace, announced today that Dr. Paul Hain, M.D. has joined the company as Chief Medical Officer. In this newly created role, Dr. Hain will work side-by-side with GoHealth's growing TeleCare team, directly building clinical functions within the recently developed Encompass Platform, a digital health solution that provides strategic value to GoHealth members and enterprise partners. Dr. Hain will focus on key member touchpoints including care management and navigation, provider and value-based care engagement, pharmacy engagement, health risk assessments, social determinant of he

    12/1/20 8:06:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Financials

    Live finance-specific insights

    View All

    GoHealth Announces Strategic Capital and Governance Actions to Support Long-Term Value Creation and Reports Second Quarter 2025 Results

    CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced the execution of strategic capital and governance actions that are expected to significantly enhance its financial flexibility and long-term positioning along with its financial results for the three and six months ended June 30, 2025. Strategic Capital and Governance Actions Secured new senior secured superpriority term loan facility, including $80.0 million in new-money term loans and $35.0 million in roll-up loans, to support working capital and stra

    8/7/25 7:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth to Announce Strategic Capital and Governance Actions to Support Long-Term Value Creation and Second Quarter 2025 Results

    CHICAGO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (GoHealth) (NASDAQ:GOCO), a leading health insurance marketplace and Medicare-focused digital health company, will announce strategic capital and governance actions to support long-term value creation and its second quarter 2025 financial results on the morning of August 7, 2025. Chief Executive Officer, Vijay Kotte, and Chief Financial Officer, Brendan Shanahan, will host a conference call and live audio webcast on the day of the release at 8:00 a.m. (ET) to discuss recent strategic capital and governance actions. A live audio webcast of the conference call will be available via GoHealth's Investor Relations websi

    8/6/25 4:15:00 PM ET
    $GOCO
    Specialty Insurers
    Finance

    GoHealth Reports First Quarter 2025 Results

    CHICAGO, May 13, 2025 (GLOBE NEWSWIRE) -- GoHealth, Inc. (NASDAQ:GOCO) ("GoHealth" or the "Company"), a leading health insurance marketplace and Medicare-focused digital health company, today announced financial results for the three months ended March 31, 2025. First Quarter Highlights First quarter 2025 net revenues of $221.0 million, a 19.1% increase compared to $185.6 million in the prior year period.First quarter 2025 net loss of $9.8 million, a 54.2% improvement compared to a net loss of $21.3 million in the prior year period.First quarter 2025 Adjusted EBITDA1 of $42.1 million, a 56.4% increase compared to $26.9 million in the prior year period.First quarter 2025 Submissions2 were

    5/13/25 7:00:00 AM ET
    $GOCO
    Specialty Insurers
    Finance

    $GOCO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

    SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

    8/25/23 6:15:20 AM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

    SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

    8/25/23 6:03:57 AM ET
    $GOCO
    Specialty Insurers
    Finance

    SEC Form SC 13D/A filed by GoHealth Inc. (Amendment)

    SC 13D/A - GoHealth, Inc. (0001808220) (Subject)

    5/19/23 6:08:49 AM ET
    $GOCO
    Specialty Insurers
    Finance